Back to Journals » Vascular Health and Risk Management » Volume 8

Doppler ultrasound venous mapping of the lower limbs

Authors Galeandro AI, Quistelli Giovanni, Scicchitano P, Gesualdo M, Zito A, Caputo, Carbonara, Galgano, Ciciarello F, Mandolesi S, franceschi C, Ciccone M

Received 25 October 2011

Accepted for publication 25 November 2011

Published 7 February 2012 Volume 2012:8 Pages 59—64


Review by Single-blind

Peer reviewer comments 4

Aldo Innocente Galeandro1, Giovanni Quistelli2, Pietro Scicchitano2, Michele Gesualdo2, Annapaola Zito2, Paola Caputo2, Rosa Carbonara2, Giuseppe Galgano3, Francesco Ciciarello4, Sandro Mandolesi4, Claude Franceschi5, Marco Matteo Ciccone2
1Centro Diagnostica Globale and ASL-TA, Taranto, Italy; 2Cardiovascular Diseases Section, Department of Emergency and Organ Transplantation (DETO), University of Bari, Bari, Italy; 3Cardiovascular Diseases Section, Ente Ecclesiastico Ospedale Generale Regionale F Miulli, Acquaviva delle Fonti, Bari, Italy; 4Cardiology Department, Policlinico Umberto I, Sapienza University of Rome, Italy; 5Vascular Laboratories of Hospitals Saint Joseph and Pitié-Salpétrière, Paris, France

Background: The study aim was to test the accuracy (intra and interobserver variability), sensitivity, and specificity of a simplified noninvasive ultrasound methodology for mapping superficial and deep veins of the lower limbs.
Methods: 62 consecutive patients, aged 62 ± 11 years, were enrolled. All underwent US-examinations, performed by two different investigators, of both legs, four anatomical parts, and 17 veins, to assess the interobserver variability of evaluation of superficial and deep veins of the lower limbs.
Results: Overall the agreement between the second versus the first operator was very high in detecting reflux (sensitivity 97.9, specificity 99.7, accuracy 99.5; P = 0.80 at McNemar test). The higher CEAP classification stages were significantly associated with reflux (odds ratio: 1.778, 95% confidence interval: 1.552–2.038; P < 0.001) as well as with thrombosis (odds ratio: 2.765, 95% confidence interval: 1.741–4.389; P < 0.001). Thus, our findings show a strict association between the symptoms of venous disorders and ultrasound evaluation results for thrombosis or reflux.
Conclusion: This study demonstrated that our venous mapping protocol is a reliable method showing a very low interobserver variability, which makes it accurate and reproducible for the assessment of the morphofunctional status of the lower limb veins.

Keywords: venous mapping, new methodology, sensitivity, specificity, accuracy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other articles by this author:

A three-dimensional electronic report of a venous echo color Doppler of the lower limbs: MEVeC®

Galeandro AI, Scicchitano P, Zito A, Galeandro C, Gesualdo M, Ciciarello F, Cecere A, Marzullo A, Contursi V, Annicchiarico A, Ciccone MM

Vascular Health and Risk Management 2014, 10:549-555

Published Date: 1 September 2014

Ivabradine, coronary artery disease, and heart failure: beyond rhythm control

Scicchitano P, Cortese F, Ricci G, Carbonara S, Moncelli M, Iacoviello M, Cecere A, Gesualdo M, Zito A, Caldarola P, Scrutinio D, Lagioia R, Riccioni G, Ciccone MM

Drug Design, Development and Therapy 2014, 8:689-700

Published Date: 3 June 2014

Waiting lists in coronary artery bypass graft patients and role of coronary angiography: the Apulian experience

Ciccone MM, Aquilino A, Frasso G, Avolio F, Contegiacomo B, Graps E, Cortese F, Dentamaro I, Petrarolo V, Salvante D, Salvatore A, Caldarola P, Scicchitano P, Bux F

Clinical Audit 2013, 5:49-55

Published Date: 14 May 2013

Cardiovascular risk evaluation and prevalence of silent myocardial ischemia in subjects with asymptomatic carotid artery disease

Marco Matteo Ciccone, Asabella Artor Niccoli, Pietro Scicchitano, et al

Vascular Health and Risk Management 2011, 7:129-134

Published Date: 4 March 2011

Readers of this article also read:

XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation

Camm AJ, Amarenco P, Haas S, Hess S, Kirchhof P, Eickels MV, Turpie AGG

Vascular Health and Risk Management 2014, 10:425-434

Published Date: 17 July 2014

Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study

Azar ST, Hantash HA, Jambart S, El-Zaheri MM, Rachoin R, Chalfoun A, Lahoud L, Okkeh O, Bramlage P, Brudi P, Ambegaonkar BM

Vascular Health and Risk Management 2014, 10:225-235

Published Date: 7 May 2014

Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

Marrett E, Zhao C, Zhang NJ, Zhang Q, Ramey DR, Tomassini JE, Tershakovec AM, Neff DR

Vascular Health and Risk Management 2014, 10:237-246

Published Date: 25 April 2014

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty

Levitan B, Yuan Z, Turpie AGG, Friedman RJ, Homering M, Berlin JA, Berkowitz SD, Weinstein RB, DiBattiste PM

Vascular Health and Risk Management 2014, 10:157-167

Published Date: 26 March 2014

The "Pulse Time Index of Norm" highly correlates with the left ventricular mass index in patients with arterial hypertension

Posokhov IN, Kulikova NN, Starchenkova IV, Grigoricheva EA, Evdokimov VV, Orlov AV, Rogoza AN

Vascular Health and Risk Management 2014, 10:139-144

Published Date: 19 March 2014

Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study

Roed T, Kristoffersen US, Knudsen A, Wiinberg N, Lebech AM, Almdal T, Thomsen RW, Kjær A, Weis N

Vascular Health and Risk Management 2014, 10:55-62

Published Date: 21 January 2014

Everolimus-eluting stents in interventional cardiology

Townsend JC, Rideout P, Steinberg DH

Vascular Health and Risk Management 2012, 8:393-405

Published Date: 27 June 2012